Member Info for Bella6532

Https://www.morningstar.com/stocks/xlon/avct/ownership

Check out fund changes as at 30 April 24...Axa Framington = 0%

These open access sites all differ and tend to be very unreliable/out of date.

LLP based on amounts raised...the % increases don't pan out do they? And based on number of shares someone needs to correct the coma placement.

Maybe waiting for it in writing to confirm acceptance...

If classed as 'significant' and they have confirmation they have been accepted they would have to RNS it immeditately...can't hold off just because they don't like issuing news on a Friday.

Beinthelead...no offence taken...when did AS say it was Axa?

Nope...and it wasn't Lombard Odier Investment Managers either. Some funds apparently don't have to report until 5% threshold crossed too....

Beinthelead..I have it from one of the Directors that AXA is not the ESF...

Also listern to CC's opening remarks in the Finals Investor Meet Presentation...lots of questions relating to the fundraise and she said she would explain more fairly soon...or somthing on those lines. Was she referring to the AGM.

Anyone on here planning to go to the AGM...???

I would loke to know who the European Specialty Fund is and has the Agreement with ADC Therapeutics come to a grinding halt? Or is it still ongoing. ADC were funding the research so I assume a full ND was put in place.

Icecool...could they be covering further investment for shares. Could it be the European Specialty Fund has indicated they may like to invest more against will receive Avacta shares...or another Fund coming in...or even a Pharma looking to Partner by way of a shareholding.

In the Year End Accounts there's one little interesting note that caught my attention. Remember I said they have to tell the markets but not necessarily divulge all the details.

P11 Second to last Para states: 'Whilst the Diagnostics Division is expected to be cash

generative in the near future, it is strategically important for the Group to simplify its structure in order to

attract specialist healthcare investors with the ability to support the growing pre-clinical and clinical pipeline

of pre|CISIONTM and Affimer® therapeutics and it will do so in a manner which maximises value and strategic

benefits for its shareholders.'

We have one SHI on board that we know of but are they now looking to attract others too...like those who invested in Levicepts.

I think the resolutions are more about inward investment not outward...

See P140 & 141 for Explanation of Special Resolutions.

https://avacta.com/wp-content/uploads/2024/05/2024-AGM-Notice.pdf

Holidays...obviously having an effect.

OK so short selling impacts we little PI's if we are forced to sell. My biggest beef is how it impacts small up and coming companies who look for initial investment and those with viable products end up getting bought out on the cheap.

Can we assume this is now dead in the water...

https://www.ipgroupplc.com/news-and-events/portfolio-news/2019/2019-10-10

Big Pharma are just like a herd of sheep...one jumps and the rest follow. It just takes one good deal.

Timster...the note said:

'AVA6000’s ongoing 2-weekly dose escalation study is expected to finish during the summer of this year.'...August would be latest I guess.

Did they ever mention the number of cohorts for 2W?

Great post JT...🙂

I wonder how much new resolution the new PET scan will offer. That's to say if current PET scans appear to show a tumour has disappeared but the new PET shows there's still an itsy bitsy bit left then this would perhaps help overcome chances of reoccurence if dosing is continued just a little longer.

Chances are several of the end of lifers may not have survived this far without AVA6000.

One day some of you out there will be desperately clinging on to what little life you have left hoping someone somewhere comes up with a magic bullet to prolong your time with family and friends. Get a life guys...go have some fun.

Oops..sorry it copied more than I

Energyshares...there are others you might wish to add to your list...

Reports

Aerospace & Defense

Agriculture

Animal Nutrition & Wellness

Automotive

Chemicals & Materials

Consumer Goods and Services

Energy & Power

Financial Services and Investment Intelligence

Food & Beverage

Healthcare

Home and Property Improvement

Hospitality and Tourism

Logistics

Manufacturing Products and Services

Packaging

Professional and Commercial Services

Real Estate and Construction

Retail

Technology, Media and Telecom

Custom Research

About

Our People

Our Clients

Careers

Contact

+1 617-765-2493

const careerItemElem = document.querySelector('.career-item');

if (careerItemElem) {

if (window.location.href.includes("mordorintelligence.com")) {

careerItemElem.style.display = 'block';

} else {

careerItemElem.style.display = 'none';

}

} else {

// console.log("Element with class 'career-item' not found.");

}

Cytotoxic Drugs Companies

This report lists the top Cytotoxic Drugs companies based on the 2023 & 2024 market share reports. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the Cytotoxic Drugs industry.

Buy Now

Download Free Sample Now

Home

Market Analysis

Healthcare Research

Pharmaceuticals Research

Active Pharmaceutical Ingredients Research

General Pharmaceuticals Research

Antineoplastics Research

Cytotoxic Drugs Market

Companies

Table of Contents

Download Sample

About This Report

Market Snapshot

Market Overview

Key Market Trends

Competitive Landscape

Major Players

Table of Contents

SCOPE OF THE REPORT

Frequently Asked Questions

Download Sample

Cytotoxic Drugs Top Companies

Teva Pharmaceuticals USA

Pfizer Inc.

Fresenius Kabi AG

Johnson & Johnson

Mylan N.V

*Disclaimer: Top companies sorted in no particular order

Cytotoxic Drugs Market Concentration

Cytotoxic Drugs Company List

Baxter Healthcare CorporationCipla LtdEli Lilly and CompanyFresenius Kabi AGJohnson & JohnsonMylan NVNovartisPfizer Inc.Sun PharmaceuticalsTeva Pharmaceuticals USA Inc. Source: https://www.mordorintelligence.com/industry-reports/cytotoxic-drugs-market/companies

Ahhh...but we got a European Heathcare Specialist investing in the Placing...they could have US connections...